Post-Ebola syndrome, Sierra Leone

Scott, J. T. , Sesay, F. R., Massaquoi, T. A., Idriss, B. R., Sahr, F. and Semple, M. G. (2016) Post-Ebola syndrome, Sierra Leone. Emerging Infectious Diseases, 22(4), pp. 641-646. (doi: 10.3201/eid2204.151302) (PMID:26983037) (PMCID:PMC4806950)

[img]
Preview
Text
165755.pdf - Published Version
Available under License Creative Commons Attribution.

857kB

Abstract

Thousands of persons have survived Ebola virus disease. Almost all survivors describe symptoms that persist or develop after hospital discharge. A cross-sectional survey of the symptoms of all survivors from the Ebola treatment unit (ETU) at 34th Regimental Military Hospital, Freetown, Sierra Leone (MH34), was conducted after discharge at their initial follow-up appointment within 3 weeks after their second negative PCR result. From its opening on December 1, 2014, through March 31, 2015, the MH34 ETU treated 84 persons (8–70 years of age) with PCR-confirmed Ebola virus disease, of whom 44 survived. Survivors reported musculoskeletal pain (70%), headache (48%), and ocular problems (14%). Those who reported headache had had lower admission cycle threshold Ebola PCR than did those who did not (p<0.03). This complete survivor cohort from 1 ETU enables analysis of the proportion of symptoms of post-Ebola syndrome. The Ebola epidemic is waning, but the effects of the disease will remain.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Scott, Dr Janet
Authors: Scott, J. T., Sesay, F. R., Massaquoi, T. A., Idriss, B. R., Sahr, F., and Semple, M. G.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Virus Research
Journal Name:Emerging Infectious Diseases
Publisher:Centers for Disease Control and Prevention
ISSN:1080-6040
ISSN (Online):1080-6059
Published Online:01 September 2016
Copyright Holders:Materials published in Emerging Infectious Diseases, including text, figures, tables, and photographs are in the public domain and can be reprinted or used without permission with proper citation
First Published:First published in Emerging Infectious Diseases 22(4): 641-646
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record